Global veterinary dermatology market is expected to reach USD 2,353.9 million in 2026 from USD 3,525.7 million in 2018 at a CAGR of 5.5% during the forecast period 2019–2026

Veterinary Dermatology Drugs Market

Atopic dermatitis is chronic skin disease associated with allergies which is caused by harmless substances like grass, mold spores, house dust mites, and other environmental allergens. Surge in prevalence of chronic skin disorders such as chewing, biting, rubbing is driving the growth of market. Furthermore, high presence of cattle and buffalo suffering from of lumpy skin disease (LSD) in European countries is major reason for boosting the growth of market. For instance, since 2012, LSD has been spread from Africa and the Middle East into south-eastern Europe, affecting European Union (EU) Member countries. Numerous autoimmune and immune-mediated cutaneous diseases such as atopic in cat and dog across the globe is in companion animals is fuelling the growth of market. Surge in number of incidence of anthrax in cattle, deer, cattle, goats, and sheep is supporting the growth of market.

The Major Players Covered in this Report:
Bayer HealthCare Animal Health Inc. (U.S.), Boehringer Ingelheim Vetmedica, Inc.(U.S.), Ceva(France), Zoetis Inc.(U.S.), Elanco(U.S.), IDEXX Laboratories(U.S.), Boehringer Ingelheim International GmbH.(France), Vetoquinol S.A.(France), and Virbac(France). 

Global veterinary dermatology market is expected to reach USD 2,353.9 million in 2026 from USD 3,525.7 million in 2018 at a CAGR of 5.5% during the forecast period 2019–2026

Get a Sample PDF Report:
https://straitsresearch.com/report/Veterinary-Dermatology-Drugs-market/request-sample

By Drug, Non-steroidal anti-inflammatory drugs (NSAIDS) , Antibiotics , Veterinary antifungal drug

By Animal Type, Large animals , Small animals

By End Users, Veterinary Hospitals , Veterinary Clinics

Segmentation insight

The veterinary dermatology drugs market is segmented into drug, animal type and end users.

On the basis of drug the veterinary dermatology drugs market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, and veterinary antifungal drug. Antibiotics veterinary medicine segment is expected to hold major market share owing to most of skin diseases caused by various bacteria.

Based on the animal type the market is segmented into large animals and small animals. High prevalence of dermatological disorders in small animals such as dog and cat as compared other animal, thus, small animals segment is dominated market and expected to grow in forecast period.

On the basis of end users the market is segmented into veterinary hospitals, veterinary clinics. Veterinary clinics is expected to hold major market share owing to control infectious animal diseases and thus reduce morbidity and mortality rate of animals. Veterinary clinics is cost effective then veterinary hospital thus, large number of patient visit the clinic.

Regional Analysis For Veterinary Dermatology Drugs Market:

North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Veterinary Dermatology Drugs are as follows:

History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2021 to 2026

The study objectives of this report are:

To study and forecast the market size of the Veterinary Dermatology Drugs in the global market.
To analyze the global key players, SWOT analysis, value, and global market share for top players.
To define, describe and forecast the market by type, end-use, and region.
To analyze and compare the market status and forecast among global major regions.
 Analyze the potential of the global market and the advantages, opportunities and challenges, constraints, and risks of key regions.
Identify the key trends and factors that are driving or holding back market growth.
To analyze the opportunities in the market for stakeholders by identifying the high-growth segments.
Strategic analysis of each submarket in light of individual growth trends and market contributions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Complete analysis of the strategic strategy and growth of key players

For More Details On this Report:
https://straitsresearch.com/report/Veterinary-Dermatology-Drugs-market

Contact Us:

Company Name: Straits Research
Email: sales@straitsresearch.com
Phone:
+1 646 480 7505 (U.S.)
+91 8087085354 (India)
+44 208 068 9665 (U.K.)

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

This release was published on openPR.